PRA Health Sciences is one of the world’s leading global contract research organizations, or CROs, providing outsourced clinical development services to the biotechnology and pharmaceutical industries. PRA provides flexible clinical development service offerings, which includes Phase I through Phase IV project based services, embedded and functional outsourcing services, and full service Bioanalytical Lab services . PRA has therapeutic expertise in oncology, central nervous system, rare/orphan diseases, inflammation and infectious diseases. We have invested heavily in medical informatics and clinical technologies which are designed to enhance efficiencies, improve study predictability and provide better transparency throughout the clinical development processes.
Close to 60% of our clients are biotechs, and over half of these are small companies (under 100 employees). PRA also routinely works with small and virtual biotech companies with decentralized key decision makers as our infrastructure and SOPs allow us to support programs with team members in different locations. PRA has conducted the pivotal trials and/or provided the key NDA support services that led to the market approval of 25 drugs for biotech companies. As a result of this experience, PRA knows how to develop non-traditional approaches for communication and information that exceed small and emerging companies’ expectations
At PRA Health Sciences, providing innovative solutions for our clients is what we do. Side-by-side with our clients, we strive to move drug discovery forward, helping them to develop life-saving and life-improving drugs.